Manufacturing News of Note—Samsung Bioepis, Biogen add to biosimilars; Boehringer Ingelheim to add 105 jobs in Puerto Rico

stocks
(Pixabay)

> Biogen and Samsung Bioepis are expanding their biosimilar agreement. Story

> Croatia has taken action against NCPC Hebei Huamin Pharmaceutical over manufacturing issues. EMA

> Boehringer Ingelheim’s animal health unit will invest nearly $50 million to expand a plant in Puerto Rico and expects to add 105 jobs. Release

Webinar

De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools

Wednesday, July 8, 2020 | 11am EST / 8am PST

This webinar will describe strategies to mitigate risks, reduce attrition and help improve the quality and safety of your drug candidate.

> Chinese biotech Akeso Pharmaceuticals will open a new GE flex facility in Guangzhou, China. Release 

Suggested Articles

Johnson & Johnson will shell out at least $480 million to Emergent BioSolutions to produce millions of doses of its COVID-19 vaccine hopeful.

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.